GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹111 Cr | ₹108 Cr | ₹125 Cr | ₹159 Cr | ₹179 Cr |
What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹159 Cr |
| Mar2021 | ₹179 Cr |
How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 2.80 | |
| Mar2024 | ₹108 Cr | -14.10 | |
| Mar2023 | ₹125 Cr | -21.01 | |
| Mar2022 | ₹159 Cr | -11.16 | |
| Mar2021 | ₹179 Cr | - | |
Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,103.2 Cr | 2.9% | -2.6% | 16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.9% |
-2.6% |
16.2% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses